Rob S. Donovan
Papers
1
Total Citations
23
H-Index
1
About
Rob S. Donovan is a pioneering figure in the field of glycobiology and drug discovery, best known for his contributions to the development of high-throughput screening methodologies. His most-cited work, "A solid-phase glycosyltransferase assay for high-throughput screening in drug discovery research" (1999), introduced a novel approach that enabled rapid, efficient identification of glycosyltransferase inhibitors, a critical step in targeting diseases such as cancer and infectious disorders. This seminal paper, with 23 citations, laid the groundwork for subsequent advances in enzymatic assay design, bridging the gap between basic glycobiology and pharmaceutical application. Donovan’s research has significantly impacted the way researchers study carbohydrate-modifying enzymes, offering a scalable platform that accelerates the discovery of therapeutic leads. His work is frequently referenced in studies on enzyme kinetics and inhibitor development, underscoring its enduring relevance. By streamlining complex biochemical processes into robust, high-throughput formats, Donovan has empowered a generation of scientists to explore glycosyltransferases as druggable targets, making him a key contributor to the intersection of chemical biology and translational medicine.
Research Focus
Key Achievements
Top Papers
- 1